Neumora Therapeutics
NMRA
#8769
Rank
S$0.15 B
Marketcap
$0.96
Share price
-5.71%
Change (1 day)
-95.15%
Change (1 year)

Neumora Therapeutics (NMRA) - Cash on Hand

Cash on Hand as of December 2024 : S$0.41 Billion

According to Neumora Therapeutics's latest financial reports the company has S$0.41 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neumora Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.41 B-30.27%
2023-12-31S$0.59 B20.26%
2022-12-31S$0.49 B-9.89%
2021-12-31S$0.55 B117.84%
2020-12-31S$0.25 B
2019-12-31N/A